NL-OMON47140CompletedPhase 3
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicenter trial. - COLOPEC
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 185
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •(1) age between 18 and 75 years. (2) adequate clinical condition to undergo re-laparoscopy or re-laparotomy within either 10 days or between week 5-8 from primary resection. (3) written informed consent (4) white blood cell count at least 3000/mm3, platelet count at least 100.000/mm3. (5) no bleeding diathesis or coagulopathy. (6) creatinine normal or creatinine clearance at least 50 ml/min.
Exclusion Criteria
- •(1) postoperative complications that interfere with adjuvant HIPEC within 8 weeks (i.e. persisting intra-abdominal abscess, significant fascial dehiscence, enteric fistula). (2) liver and/or lung metastases. (3) pregnant or lactating women. (4) unstable or uncompensated respiratory or cardiac disease. (5) serious active infections. (6) other concurrent chemotherapy. (7) hypersensitivity for fluorouracil folinic acid (calciumfolinate) or another substance of leucovorin or Oxaliplatin. (8) Stomatitis, ulceration in the mouth or gastrointestinal tract. (9) severe diarrhea (10) severe hepatic and / or renal dysfunction. (11) plasma bilirubin concentrations greater than 85 *mol/l. (12) Pernicious anemia or other anaemias due to vitamin B12 deficiency.(13) peripheral sensory neuropathy with functional impairment.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Intraperitoneal hyperterm chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal origiAdjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosisthe COLOPEC randomized multicenter trialEUCTR2014-002794-11-NLAcademic Medical Center176
Active, not recruiting
Not Applicable
Hyperthermic intra-peritoneal chemotherapy (HIPEC) in Ovarian cancer recurrence: Randomized trial on Survival Evaluation.Ovarian cancerEUCTR2012-002872-15-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Recruiting
Not Applicable
Study of Hyperthermic intraperitoneal chemotherapy(HIPEC) for peritoneal dissemination and appendiceal mucinous neoplasmJPRN-UMIN000016360Mie university gastrointestinal and pediatric surgery10
Active, not recruiting
Not Applicable
Surgery plus intraperitoneal hyperthermic chemoterapy in platinum-resistant patients with ovarian cancer reccurrence. A Phase II study.EUCTR2005-000929-31-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Active, not recruiting
Not Applicable
Surgery plus intraperitoneal Hypertermic chemotherapy in platinum-sensitive patients with ovarian cancer recurrence after 12 months. Phase II studyRecurrent ovarian cancerMedDRA version: 6.1Level: PTClassification code 10033128EUCTR2005-000927-41-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI